Novo CEO pressed by Senate to chop selling prices of obesity, diabetic issues medicines CEO Lars Fruergaard Jørgensen explained to lawmakers the business would take into consideration new talks with insurers concerning the checklist selling prices of Wegovy and copyright if they pledge to help keep the medicines on their https://erickdczyt.losblogos.com/30045918/an-unbiased-view-of-healthcare-news